Drug Profile
OPNT 006
Alternative Names: ONPT-006; Opioid antagonist implant - Opiant PharmaceuticalsLatest Information Update: 06 Mar 2023
Price :
$50
*
At a glance
- Originator Opiant Pharmaceuticals
- Class Drug withdrawal therapies; Morphinans; Opioid analgesics
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Opioid-related disorders
Most Recent Events
- 02 Mar 2023 Opiant Pharmaceuticals has been acquired by Indivior
- 09 Sep 2020 Discontinued - Preclinical for Opioid-related disorders in United Kingdom (SC) before September 2020 (Opiant Pharmaceuticals, September 2020)
- 02 Oct 2017 Titan Pharmaceuticals and Opiant Pharmaceuticals agree to develop opioid antagonist implant